The Pfizer/BioNTech COVID-19 vaccine was safe and effective in 12- to 15-year-olds in a clinical trial, and the companies will seek emergency use authorization for the age group, Pfizer CEO Albert Bourla announced.
Pfizer says COVID-19 vaccine effective in young teens
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.